Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Tariff Impact Weighs on Terumo Despite Strong North America Growth And OrganOx Gains
Feb 17 2026
•
By
Shubham Singh
Speaking on the company’s outlook, Hagimoto said Terumo is progressing steadily toward achieving its five-year Growth Strategy 2026 goals, underpinned by strong underlying fundamentals. Picture Credit: Shutterstock
More from Strategy
More from Business